Display Settings:

Format

Send to:

Choose Destination
    Clin Breast Cancer. 2011 Oct;11(5):342-5. Epub 2011 May 14.

    Effective role of hormonal therapy in metastatic primary neuroendocrine breast carcinoma.

    Source

    Department of Hematology/Oncology, UMass Memorial Medical Center, Worcester, MA 01655, USA.

    Abstract

    Primary neuroendocrine carcinoma (PNEC) of the breast is extremely rare.(1) Because of the rarity of this cancer, long-term prognosis, biologic behavior, and treatment are not well known. PNEC can have high expression of estrogen receptor (ER) and progesterone receptor (PR). It is important to differentiate PNEC of the breast from other metastatic diseases to the breast because of the differences in treatment. We herein report the successful treatment of a patient with PNEC of the breast and high expression of ER and PR by means of hormonal therapy.

    Copyright © 2011. Published by Elsevier Inc.

    PMID:
    21729664
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk